Your browser doesn't support javascript.
loading
Chimerism Assay Using Single Nucleotide Polymorphisms Adjacent and in Linkage-Disequilibrium Enables Sensitive Disease Relapse Monitoring after Hematopoietic Stem-Cell Transplantation.
Kim, JinJu; Yun, Woobin; Park, Yu Jin; Seo, Jieun; Lee, Richard Dong Wook; Shin, Saeam; Lee, Hyun-Ji; Kim, In Suk; Choi, Jong Rak; Lee, Seung-Tae.
Afiliação
  • Kim J; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Yun W; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, South Korea.
  • Park YJ; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Seo J; Department of Laboratory Medicine, Armed Forces Yangju Hospital, Gyeonggi-do, South Korea.
  • Lee RDW; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Shin S; Dxome Co. Ltd, Seongnam-si, Gyeonggi-do, South Korea.
  • Lee HJ; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim IS; Department of Laboratory Medicine, Pusan National University, Yangsan Hospital, Yangsan, South Korea.
  • Choi JR; Department of Laboratory Medicine, Pusan National University, School of Medicine, Pusan, South Korea.
  • Lee ST; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Clin Chem ; 67(5): 781-787, 2021 04 29.
Article em En | MEDLINE | ID: mdl-33582770
ABSTRACT

BACKGROUND:

Short tandem repeat (STR)-based chimerism analysis has been widely used for chimerism monitoring after hematopoietic stem-cell transplantation (HSCT), but technical artifacts can be problematic. We designed a chimerism assay using single nucleotide polymorphisms (SNPs) adjacent and in linkage-disequilibrium (CASAL), which doubly checked for SNP pairs, and thus could reduce background errors and increase analytical sensitivity.

METHODS:

CASAL targeted 84 SNP pairs within 10 bp distance and in perfect linkage-disequilibrium. Using undiluted and serially diluted samples, baseline error rates, and linearity was calculated. Clinical performance of CASAL was evaluated in comparison with a conventional STR assay, using 191 posttransplant samples from 42 patients with HSCT.

RESULTS:

CASAL had ∼10 times lower baseline error rates compared to that of ordinary next-generation sequencing. Limit of detection and quantification of CASAL were estimated to be 0.09 and 0.39%, respectively, with a linear range of 0.1-100%. CASAL correlated well with STR assay (r2 = 0.99) and the higher sensitivity enabled detection of low-level recipient chimerism and earlier prediction of relapse.

CONCLUSIONS:

CASAL is a simple, analytically sensitive and accurate assay that can be used in clinical samples after HSCT with a higher performance compared to that of traditional assays. It should also be useful in other forensic and archeological testing.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Polimorfismo de Nucleotídeo Único Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Polimorfismo de Nucleotídeo Único Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article